Sorafenib in patients with progressed and refractory bone tumors

about

Sorafenib in patients with progressed and refractory bone tumors

Item

http://www.wikidata.org/entity/Q58774317

description

im August 2018 veröffentlichter wissenschaftlicher Artikel

@de

scientific article published on 16 August 2018

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована в серпні 2018

@uk

name

Sorafenib in patients with progressed and refractory bone tumors

@en

Sorafenib in patients with progressed and refractory bone tumors

@nl

type

Item

label

Sorafenib in patients with progressed and refractory bone tumors

@en

Sorafenib in patients with progressed and refractory bone tumors

@nl

prefLabel

Sorafenib in patients with progressed and refractory bone tumors

@en

Sorafenib in patients with progressed and refractory bone tumors

@nl

P1476

Sorafenib in patients with progressed and refractory bone tumors

@en

P2093

Katarzyna Bilska

http://www.w3.org/2001/XMLSchema#string

P2860

Osteosarcoma: Current Treatment and a Collaborative Pathway to Success

Sorafenib and everolimus for patients with unresectable high-grade osteosarcoma progressing after standard treatment: a non-randomised phase 2 clinical trial.

Outcome for adolescent and young adult patients with osteosarcoma: a report from the Children's Oncology Group.

Phase 2 trial of sorafenib in children and young adults with refractory solid tumors: A report from the Children's Oncology Group.

Long-term Outcome of Chondrosarcoma: A Single Institutional Experience.

Advances in paediatric cancer treatment

Phase I and clinical pharmacology study of bevacizumab, sorafenib, and low-dose cyclophosphamide in children and young adults with refractory/recurrent solid tumors.

Safety, pharmacokinetics, and preliminary antitumor activity of sorafenib: a review of four phase I trials in patients with advanced refractory solid tumors.

Analysis of prognostic factors in ewing sarcoma family of tumors: review of St. Jude Children's Research Hospital studies.

Advanced chondrosarcomas: role of chemotherapy and survival.

P2888

s12032-018-1180-x

P304

126

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12032-018-1180-X

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Anna Raciborska

P577

2018-08-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30116912

http://www.w3.org/2001/XMLSchema#string

P921

hematology

cancer research

P932

6097021

http://www.w3.org/2001/XMLSchema#string